Cargando…

Correction: Dissecting signalling pathways associated with intrarenal synthesis of complement components in lupus nephritis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403125/ https://www.ncbi.nlm.nih.gov/pubmed/35999029 http://dx.doi.org/10.1136/rmdopen-2022-002517corr1

Ejemplares similares

Dissecting signalling pathways associated with intrarenal synthesis of complement components in lupus nephritis
por: Tampe, Desiree, et al.
Publicado: (2022)

Correction: Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
por: Reddy, Padmalatha S, et al.
Publicado: (2009)

Association of Serum CXCL13 with Intrarenal Ectopic Lymphoid Tissue Formation in Lupus Nephritis
por: He, De Ning, et al.
Publicado: (2016)

Association of Intrarenal B-Cell Infiltrates with Clinical Outcome in Lupus Nephritis: A Study of 192 Cases
por: Shen, Yan, et al.
Publicado: (2012)

Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritis
por: Pamfil, Cristina, et al.
Publicado: (2018)

Diagnostic performance of serum cystatin C and complement component 1q in lupus nephritis
por: Xu, Bei, et al.
Publicado: (2019)

Molecular signatures of intrarenal complement receptors C3AR1 and C5AR1 correlate with renal outcome in human lupus nephritis
por: Tampe, Désirée, et al.
Publicado: (2022)

Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy
por: Na, Woong, et al.
Publicado: (2017)

Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)

Microarray-based analysis of renal complement components reveals a therapeutic target for lupus nephritis
por: Liu, Tao, et al.
Publicado: (2021)

Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
por: Li, Nicholas L., et al.
Publicado: (2021)

Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice
por: Li, Bin, et al.
Publicado: (2020)

INTRARENAL COMPLEMENT FIXATION BY CYTOTOXIC ANTIBODIES
por: Sellin, D., et al.
Publicado: (1970)

Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages
por: Zhang, Ting, et al.
Publicado: (2020)

Correction: Knockdown of DEC2 expression inhibits the proliferation of mesangial cells through suppressed glycolysis and p38 MAPK/Erk pathway in lupus nephritis
por: Qi, Huimeng, et al.
Publicado: (2023)

Something old, something new: Na(+)/K(+)/ATPase as a mechanism of intrarenal B cells viability in lupus nephritis
por: Zakrocka, Izabela, et al.
Publicado: (2023)

Correction: CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms
por: Ripoll, Èlia, et al.
Publicado: (2013)

Correction to: Kidney biopsy in lupus nephritis after achieving clinical renal remission: Paving the way for renal outcome assessment
Publicado: (2023)

Case report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation
por: Nozal, Pilar, et al.
Publicado: (2015)

The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
por: Shi, Yu, et al.
Publicado: (2019)

Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis
por: Tan, Ying, et al.
Publicado: (2013)

Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
por: Torres, Everardo Arias, et al.
Publicado: (2021)

Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway
por: Macedo, Ana Catarina Lunz, et al.
Publicado: (2016)

Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation
por: Zhang, Binshan, et al.
Publicado: (2022)

Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis
por: Radanova, Maria, et al.
Publicado: (2022)

Aberrant Activation of the WNT/β-Catenin Signaling Pathway in Lupus Nephritis
por: Wang, Xiao-dong, et al.
Publicado: (2014)

Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
por: Reddy, Padmalatha S, et al.
Publicado: (2008)

Author Correction: Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities
por: Stanley, Samantha, et al.
Publicado: (2020)

Complement Factor I Mutation May Contribute to Development of Thrombotic Microangiopathy in Lupus Nephritis
por: Tseng, Min-Hua, et al.
Publicado: (2021)

The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare
por: Toy, Chris R., et al.
Publicado: (2021)

GBP2 acts as a member of the interferon signalling pathway in lupus nephritis
por: Zhang, Yuan, et al.
Publicado: (2022)

Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin
por: Chung, Sungjin, et al.
Publicado: (2018)

A Transcriptome Array-Based Approach Links Proteinuria and Distinct Molecular Signatures to Intrarenal Expression of Type I Interferon IFNA5 in Lupus Nephritis
por: Korsten, Peter, et al.
Publicado: (2023)

Activation of Intrarenal Complement System in Mouse Model for Chronic Cyclosporine Nephrotoxicity
por: Kim, Young Ok, et al.
Publicado: (2007)

Correction To: Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus
por: Han, Xiaojuan, et al.
Publicado: (2022)

4336 Renal Tubular Complement C9 Deposition is Associated with Renal Tubular Damage and Fibrosis in Lupus Nephritis
por: Wang, Shudan, et al.
Publicado: (2020)

Association of C-reactive protein and complement factor H gene polymorphisms with risk of lupus nephritis in Chinese population
por: Li, Qiu-Yu, et al.
Publicado: (2023)

Novel Autoantigens Associated with Lupus Nephritis
por: Onishi, Sachiko, et al.
Publicado: (2015)

Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis
por: Ma, Haijun, et al.
Publicado: (2018)

Anti-complement factor H (CFH) autoantibodies could delay pristane-induced lupus nephritis
por: Li, Lin-Lin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qi004gjksbprchleenr6btc0h8